chr14-21033918-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001012264.4(RNASE13):āc.371A>Gā(p.Tyr124Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00046 in 1,614,032 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001012264.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASE13 | NM_001012264.4 | c.371A>G | p.Tyr124Cys | missense_variant | 2/2 | ENST00000382951.4 | NP_001012264.1 | |
NDRG2 | NM_001282211.2 | c.25-10597A>G | intron_variant | NP_001269140.1 | ||||
TPPP2 | XM_011536416.2 | c.328-2273T>C | intron_variant | XP_011534718.1 | ||||
TPPP2 | XM_011536420.3 | c.*13+1538T>C | intron_variant | XP_011534722.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000487 AC: 74AN: 152104Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000513 AC: 129AN: 251452Hom.: 0 AF XY: 0.000500 AC XY: 68AN XY: 135890
GnomAD4 exome AF: 0.000458 AC: 669AN: 1461810Hom.: 3 Cov.: 31 AF XY: 0.000506 AC XY: 368AN XY: 727216
GnomAD4 genome AF: 0.000486 AC: 74AN: 152222Hom.: 0 Cov.: 31 AF XY: 0.000390 AC XY: 29AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.371A>G (p.Y124C) alteration is located in exon 2 (coding exon 1) of the RNASE13 gene. This alteration results from a A to G substitution at nucleotide position 371, causing the tyrosine (Y) at amino acid position 124 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at